**REGISTERED COMPANY NUMBER: 01676618 (England and Wales) REGISTERED CHARITY NUMBER: 286197**
## **Report of the Trustees and**
**Unaudited Financial Statements for the Year Ended 31 December 2021**
**for**
**The British Toxicology Society**
Sutton McGrath Hartley 5 Westbrook Court Sharrowvale Road Sheffield South Yorkshire S11 8YZ
**The British Toxicology Society**
## **Contents of the Financial Statements for the Year Ended 31 December 2021**
||**Page**|
|---|---|
|**President's Report**|1 to 8|
|**Operating and Financial Review**|9 to 10|
|**Report of the Trustees**|11 to 12|
|**Independent Examiner's Report**|13|
|**Statement of Financial Activities**|14|
|**Balance Sheet**|15 to 16|
|**Notes to the Financial Statements**|17 to 23|
|**Detailed Statement of Financial Activities**|24 to 26|
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
As a Society we have continued to promote the positive impact of toxicology, and to support and represent members in all areas we represent. I am delighted that we have been able to maintain a constant membership level of 981 members which has been another increase on last year. I would like to thank our members for your continued support of the Society.
September 2021 marked 50 years since the inception of the BTS. It started from very humble beginnings, when in 1971 (the year decimalisation was introduced) two University of Surrey staff members, namely Professors Jim Bridges and Ron Walker, formed the Toxicology Club. It is amazing how a discussion at 2am in the morning in a KUB (Kitchen, Utility and Breakfast room in Surrey speak!!) at the University led eventually to the founding of the British Toxicology Society in 1979- the Society we know now! Those humble beginnings set out the path for a Society whose remit has always been to promote the advancement of the science of toxicology, for public benefit. The Toxicology Club membership initially was made up of UK based toxicologists, but the Society is proud to have, amongst its numbers, many members from across the world. Members total around 900 currently and work in academic, clinical, governmental, and industrial organisations.
The Executive Committee have discussed the 2020-2024 Strategic Vision of the Society at its meetings over the last year to ensure that the aims are being met and, where required, updated. The Strategy for 2020-2024 can be found on the website (Strategy-of-the-BTS-2020-2024- 2020). This year several updates and commitments to the previous strategy were made taking on board members' feedback. We will shortly publish an updated Strategy which will take the Society through to the end of 2026 and we will share details of this with members over the coming months.
In addition to overarching Strategy 2020-24 we have set out our Equality, Diversity and Inclusion (EDI) Strategy and I am pleased to welcome our EDI co-opted member, Professor Winston Morgan, to the Executive Committee.
Professor Morgan will work with Drs Emma Marczylo and David Mason to drive our EDI agenda. We have also applied to join the Equality, Diversity and Inclusion in Science and Health (EDIS) organisation to support our work in the EDI arena. EDIS is a coalition of organisations working to improve equality, diversity and inclusion within the science and health research sector, originally established by the Francis Crick Institute, Wellcome Trust and GlaxoSmithKline . I will be able to update the membership at the AGM in April 2022 to confirm if our application to EDIS was successful. For more details on EDIS please visit their website: https://edisgroup.org/
## **Co-opted Members for 2022-2024**
At every Annual General Meeting (AGM) I, as your President, need to inform you of those members who have been co-opted to vacancies on the Executive Committee. These positions were advertised to the membership during the year.
Dr Helen Nakeeb has been appointed to the Chair of the Education, Career and Training Development (ECTD) Subcommittee. Dr Nakeeb succeeds Dr Tina Mehta and takes up this position as on the 4th April 2022. Dr Nakeeb applied, and was recommended, for this position to the Executive Committee by the Nominations Subcommittee. The Executive Committee was in full agreement to support this application of Dr Nakeeb for the co-opted position as Chair of the ECTD Subcommittee. As this is a co-opted position it does not need to be ratified at the AGM. The term of office is 3 years, but the Chair can be proposed to serve for a second term. I would like to welcome Dr Nakeeb to the Executive Committee.
Professor Morgan has been appointed to the role of EDI Co-ordinator. Professor Morgan accepted this position on 26th January 2022. This appointment was made through a competitive process. All applicants were interviewed, and the decision of the Interview Panel (Drs Carol Courage, Emma Marczylo and David Mason) was ratified by the Executive Committee. This is a co-opted position which does not need to be ratified at this AGM. The term of office is 3 years, but the holder can be proposed for a second term. I would like to welcome Professor Morgan to the Executive Committee.
## **Awards to our Members 2021/22**
Before presenting some of the highlights from this year I would like to acknowledge some of the awards received by our members in 2021/22.
Page 1
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
- Our congratulations to Professor Diana Anderson, Established Chair of Biomedical Sciences, University of Bradford, on being awarded an MBE in the 2022 New Year's Honours list, for services to Genetic and Reproductive Toxicology. - I would like to take this opportunity to congratulate Professor Ruth Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath for being the first UK recipient of the Mildred S, Christian Career Achievement Award for 2022. This is awarded to Professor Roberts by the Academy of Toxicological Sciences (ATS). ATS established the Mildred S.Christian Career Achievement Award to honour the memory of Dr Christian. The award is conferred upon an ATS Fellow who has clearly demonstrated a lasting impact on toxicological sciences.
- Congratulations to Dr Diane Benford and Professor Ian Kimber, OBE, on being awarded Honorary Lifetime Membership of the Society
- Our congratulations to Professor Faith Williams, the 2022 Paton Prize winner, and Dr Gillian Conway the first recipient of the Malcolm Blackwell award at this year's Annual Congress.
- Congratulations to Dr Any Chadwick who was awarded the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Lectureship Award 2021.
I am pleased to provide a summary of what has been accomplished since the last AGM and I hope that this is helpful and of interest. Details of some of what is presented below is provided in the relevant reports from the Chairs of the subcommittees.
## **Risk Register**
We took the opportunity to review and update the Society's Risk Register and to consider any effects the pandemic may have had/will have on the sustainability of the Society. I am pleased to report that as a Society the pandemic did not have a significant adverse effect on our finances and the Society remains in a sustainable position.
The main subcommittees of the Society have been very active over the last year, and it has been a pleasure to be able to attend some of their virtual meetings to meet with the members and hear what is going on first-hand.
## **Membership**
The Membership of the BTS has continued to increase, with 981 members as of December 2021. It is good to see this continual increase in numbers, although the Executive Committee are keen to ensure these numbers continue to increase and that we ensure we meet our mission "To provide the principal forum for toxicology in the UK, to support and enrich the carers of toxicologists, and to promote the importance and advancement of toxicology in the wider and lay communities".
My thanks to Lisa Godfrey, our Membership Facilitator who has been undertaking a lot of work to promote membership of the Society and the benefits offered to our members. A list of current benefits can be found here https://www.thebts.org/wp-content/uploads/2020/11/Members-Benefits-June-2020.pdf
I am sure over the coming months you will be hearing from Lisa to gauge your views as members and what more can be done to support our members and attract new members to the Society.
## **Retirement Policy**
The Executive Committee considered the subscription payable by our retired members and whether we are in line in line with that of other Societies. It was proposed to increase the fee payable by our retired members from 40% to 50% of the full membership fee.
Following discussions with a Focus Group, representing members of the Society, and chaired by Professor Heather Wallace, they raised a number of points for the Executive Committee to consider:
- that retired members added value to the Society and, in particular at the Annual Congresses. While no one felt the rise in the cost from 40% to 50% of the full membership fee was prohibitive it was agreed that any increase in the fee payable should occur at the same time as other increases in Society membership fees (even if this meant a greater proportionate increase for retirees).
- that the definition of "retired" was to be considered as "a decrease in activity in toxicology to < 25% of previous workload and no significant income from toxicology."
- that the Society should consider offering the retired members some benefit for their membership and the Executive Committee should consider this and bring any proposals to the 2023 AGM.
Page 2
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
- that the Executive Committee consider a reduction in the registration fee for retired members to the Annual Congress from 2023. The proposal was either a 25% reduction in the overall full registration fee or a charge the equivalent of a one day registration fee to attend the full Congress.
It was clear from discussions that the change in the percentage of the fee payable by a retired member from 40% to 50% of the full membership fee was not an issue from the discussions with the Focus Group, providing any increases in fees were undertaken at the same time as any increases being considered for the membership fees payable by full members. The agreement was that if the fee was to be increased it would not be levied until all membership fees were increased.
The proposal regarding the increase in the fee payable from 40% to 50% of the full membership fee was considered by the Executive Committee at its meeting on the 26th January 2022 taking into account the views of the Focus Group and members of the Executive Committee and the following was agreed following a vote:
- By a majority, the retirement fee should remain at the current level of 40% of the full membership fee.
The proposal by the Focus Group regarding the definition for retirement was considered by the Executive Committee at its meeting on the 26th January 2022 .
- The Executive Committee unanimously agreed to adopt the definition of retirement as proposed by the Focus Group. The definition is "Retirement is a decrease in activity in toxicology to < 25% of previous workload and no significant income from toxicology". This definition will be guidance only
The other two proposals from the Focus Group will be considered by the Executive Committee at its meetings in the coming year and the outcomes reported to the membership at the 2023 AGM.
I would like to take this opportunity to thank Professor Wallace and the Focus Group for their considered comments on this issue.
## **Project Co-ordinator: Skills gap in Toxicology**
In 2021 the Executive Committee supported the initiative for the BTS to lead on looking at the Skills Gap in Regulatory Toxicology. The Project Co-Ordinator Role was advertised through the BTS website, and we received a number of applications. The Interview Panel (Drs Phil Botham, Emma Barnes, Cath Mulholland, David Gott and myself) considered the applicants and after shortlisting and interviews we were pleased to appoint Dr Sarah Judd, Newcastle University. Sarah who is working as a consultant to the BTS is consulting with industry, regulatory, NGOs and academia representatives to understand and identify gaps in training. This appointment is for a period of 6 months in the first instance working with the Executive Committee and there will be regular updates on progress through the Newsletter and website. A final report will be published later this year as to the findings and conclusions of this exercise.
## **Work of the Subcommittees**
The main subcommittees of the Society have been very active over the last year, and it has been a pleasure to be able to attend some of their virtual meetings to meet with the members and hear what is going on first-hand.
The sustainability of the Society depends on ensuring that there is a clear succession plan in place and the Nomination Subcommittee (NSC), chaired by Dr Chris Powell, oversees this activity on behalf of the Executive Committee and we are in a very secure position going forward. As always, if you would like to be considered as a member of a subcommittee or Chair, please send your name and a short biography to bts@execbs.com
The NSC have also considered exceptional applications for the Paton Prize. The Paton Prize is in honour of Sir William Paton to encourage scholarships in the historical aspects of toxicology. This year the recipient is Professor Faith Williams.
The Mid-Career Achievement Award, made in recognition of the achievements of an exceptional mid-career member of the BTS, will also be awarded at the Annual Congress but at the time of writing the recipient had not been confirmed.
Page 3
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
The Society's finances are overseen by our Treasurer, Professor Rob Chilcott, and the Finance Subcommittee (FSC), chaired by Professor Brian Lake. More detail of the Society finances will be provided in the Treasurer's Report.
Our independent examiners at Sutton McGrath Hartley review the accounts to ensure we meet the requirements of the Charity Commission .
This year the Executive Committee have considered a proposal to increase the membership fees from January 2023. The proposal will be provided by the Treasurer, and this will be considered at the AGM.
One key area to highlight regarding our finances is that donations this year have been very encouraging: the Society received £11,250 in 2021, with a further £7,750 since January this year giving a total of £18,800 for 21/22. The donations help support the work of the Society and we are extremely grateful for this support.
Donating companies for this period were AstraZeneca, ApconiX, Charles River Laboratories, Delphic HSE, GlaxoSmithKline, Syngenta, and Unilever. My thanks to all those companies who have supported the BTS through these generous donations this year which allow the Executive Committee to support many initiatives including the Congress, webinars, scholarships, and bursaries.
My thanks also to those companies who have supported the Congress which include: ApconiX, Bibra, Toxicology Advice and Consulting Ltd , Cyprotex, National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Oxford University Press, Royal Society of Chemistry and Sequani.
The Scientific Subcommittee (SSC) which is led by Drs Jason Gill (Chair) and Lesley Reeve (Vice-Chair) has been as proactive as ever, changing tack from a virtual Annual Congress to a face to face Annual Congress given the lifting of restrictions due to the pandemic which takes time and energy, and I am pleased to report that the Congress this year is of the same high standard as ever.
The 2021 Congress could not be delivered as a face to face meeting in April due to the Pandemic, but the Hybrid meeting was a success and Dr Gill will provide more details in his report. I am, however, pleased that the 2022 Congress is being delivered as an in person meeting at The Newcastle Hilton, Gateshead.
As part of the SSC there are a number of Speciality groups. It is a pleasure to report that the Subspeciality sections have made a significant contribution to the Society and this year is no exception The Speciality Sections are thriving and include:
- Computational and in silico Toxicology (Co-ordinator: Dr Andreas Bender);
- Clinical and Human Toxicology (Co-ordinator: Dr James Coulson);
- Regulatory Toxicology (Co-ordinator: Dr Miriam Jacobs);
- Mechanistic and Discovery Toxicology (Co-ordinator: Dr Muireann Coen);
- Risk Assessment (Co-ordinator: Dr Susie Brescia).
My thanks to all the co-ordinators for their hard work with engaging with members and supporting the Society. Several of the Speciality Sections are providing symposia at this year's Congress. Each of the Speciality Sections have also provided networking meetings which started in October 2020.
Dr Miriam Jacobs chaired a successful two day workshop in November on "An Awareness Event: Current Status of New Approach Methodologies (NAMs) for Regulatory Purposes". This event aimed to increase awareness and understanding of current and near future international regulatory developments for NAMs for chemical hazard and human risk assessment. The event addressed the BTS and IGHRC training requirements in raising awareness and understanding of the current status of the internationally-accepted regulatory science basis.
The Society has several Prizes and Travel Scholarships available so please do look at what is on offer at https://www.thebts.org/events-2/awards-and-prizes/.
Page 4
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
The Education, Training and Career Development Subcommittee (ETCD), chaired by Dr Tina Mehta, were able to provide the Continuing Education Programme (CEP) virtually in 2021. The topic, which was well received, was "COVID-19 repurposing therapies and vaccines". The CEP sessions are available as audio recordings to our members on the BTS website.
This year the CEP is on a very topical area "Risk Assessments - Across the Sectors":
The ETCD have also been promoting the mentoring scheme to the membership which is free. Senior toxicologists who are willing to provide individual career advice to other members are listed on the website. It has been suggested that some senior members might also benefit from opportunities to being mentored-known as Reverse Mentoring where a member in their early career enters into a "professional friendship" with someone more senior. For more information, please see http://www.thebts.org/membership/mentoring/
Although the Royal Society of Biology Careers Fair were not available as a face to face event this year there was a virtual meeting in November and members of the BTS ETCD subcommittee provided support to members for careers. The ECTD are currently in the process of working with an external organisation to improve the information provided on career opportunities in Toxicology on the BTS website.
The Communication Subcommittee (CSC), chaired by Dr David Woolley , has maintained communication channels with the membership through initiatives such as the Ambassadors Scheme (led by Dr Kirsti Hornigold), the NewsFeed (Editorial Team: Drs Guy Healing, David Woolley, Rani Ghosh and David Jones) and promoting social media channels (Drs Malgorzata.Kurzawa-Zegot and Kemal Haque).
We also welcomed Dr Kirsti Hornigold, MRC Toxicology Unit, University of Cambridge, who has taken on the role of Lead Ambassador Co-ordinator for the Society. This role is the focal point between BTS Ambassadors and the BTS Executive Committee and will be to help the BTS build, support, and improve its network of Ambassadors. The BTS Ambassador scheme aims to deliver and promote the Society's vision and objectives for the science of toxicology at a local level. Kirsti will be a member of the Communication Subcommittee (CSC) and work closely with David Woolley who chairs the CSC. Kirsti will be looking forward to speaking with members about the Ambassador Scheme over the next few months. In the meantime, if your company or institution does not have an Ambassador, please contact bts@execbs.com to discuss your interest. Further information can be found here. If you would like to get in touch with your nearest ambassador to find out more about the BTS or to run a local meeting contact bts@execbs.com
Regional meetings for local networking have also been delivered virtually which have been promoted and organised by the BTS Ambassadors. Dr David Woolley co-ordinated the Ambassador's Scheme and my thanks to you, David and the Ambassadors for supporting the Society in so many ways. As normality returns there will be opportunities to host additional local meetings in the coming year and if you are looking to organise a meeting, grants of up to £250 are available from the BTS to cover meeting costs and refreshments.
Drs Malgorzata.Kurzawa-Zegot and Kemal Haque have been working behind the scenes to promote the various social media platforms the Society uses, so if you are not already on the LinkedIn platforms or Twitter, please do consider these outlets to promote the work of the BTS. Our Twitter account is @BritToxSoc so do please use it to promote the Society. The BTS also has a LinkedIn page and this can be accessed through the following link: https://www.thebts.org/news/bts-joins-linkedin/
In the past year, the Public Communication Steering Team chaired by Dr Phil Botham has produced several public statements which provide authoritative, educational comment on a toxicology related topic of interest. The full list of public statements on our website are:
- Environmental Causes of Cancer
- Microbiome and Toxicology
- Micro Physiological Systems
- Alternative (In Vitro) Approaches to Toxicity Testing
- Safety Testing Vaccines COVID-19
- Assessing the Safety of Genetically Modified Crops
- The Safety of Cell Therapies
- Unravelling Air Pollution with Toxicological Science
Page 5
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
- Use of Animals in Toxicology and Safety Science
- Distinguishing Hazard and Risk
- Computational Models in Chemical Safety Assessment
- E-Cigarettes and Vaping Infograph
- Decade of Toxicological Trends
Drs Bryony Ross and Trudy Knight joined the Public Communications Steering Team in 2021 following interviews for these positions.
The Executive Committee also recognised that our early career scientists have a particular role to play, both within the BTS and in the broader scientific community. Having looked at our membership of subcommittees and the Executive Committee it was felt that that the voices of those at an early stage in their career were under-represented. We have now established the 'Network for Early Stage Toxicologists' (NEST) as an opt-in community, making best use of social media, as well as face to face networking opportunities at congresses, to build a community and feed ideas into the Executive Committee to support those at an early stage of their career.
The NEST, chaired by Nevine Amer, University of Hertfordshire, is tasked with coordinating early career networking, as well as career's outreach in universities, giving scientific input to help shape the BTS Congress, and also providing early career representation on the various subcommittees of the Society and in particular Scientific, Communication and Education, Training and Career Development (ETCD).
NEST have been very active in organising Podcasts with some of our established toxicologists and these will be an addition to the website in the months to come.
From April 2022, Nevine will also be a member of the Nominations Subcommittee to ensure our early stage toxicologists are represented.
We were also pleased that in this 50th year we are also able to celebrate the first recipient of the Malcom Blackwell Award to Dr Gillian Conway, Swansea University. This award in recognition of an individual deemed inspirational, impactful and a role model to members of the NEST. Dr Conway will be presenting her lecture, "Using In Vitro 3D Liver Models for the Development of Hazard Assessment Protocols Following Exposure to Engineered Nanomaterials" at the Annual Congress on Monday 4th April at 17.45 where she will receive the award and deliver the NEST invitation lecture.
As the BTS is a registered charity, committee members of the BTS are volunteers and without their willing help, the Society would simply not be able to exist. There are always opportunities for members to get involved. If you are interested in helping the Society by being a member of the Executive Committee or the subcommittees, please contact bts@execbs.com. Even if no suitable opportunity is available now, it is very helpful for planning purposes, to be aware of expressions of interest for roles on committees from our members.
## **BTS Website Update**
The Executive Committee decided, based on feedback from members, that the website needed an overhaul. A tendering process was undertaken, and Insights Design and Printing Ltd undertook this project and the website will be launched following the AGM. My thanks to Dr Fiona Sewell for leading on this project.
## **Toxicology Research**
The Official Journal of the BTS, Toxicology Research, now published by Oxford University Press (OUP), has increased its impact fact to 3.524. We are delighted to work with OUP and its Editor-in-Chief, Professor Heather Wallace. We are happy to have negotiated a great discount for our members for online subscriptions to the journal. The cost to BTS members is just £60, which is less than 4% of the institutional subscription. If you would like to take up this offer, you can apply at: https://academic.oup.com/toxres/subscribe. Professor Wallace is also a co-opted member of the Executive Committee.
I am also pleased to report that the OUP are supporting the BTS with a prize for the best student communication to the value of £100.00 of OUP books.
Page 6
**The British Toxicology Society**
## **President's Report for the Year Ended 31 December 2021**
## **Interaction with other Societies**
One of the strategic objectives of the BTS is to promote interactions with other scientific societies and organisations to meet our vision to "drive excellence in toxicology". Our work with other Learned Societies and Professional Bodies ensures we have a voice, feed into consultations applicable to the discipline of Toxicology and have seat at the table to lobby the Government where required. It is a pleasure to work closely with the following organisations:
- UK Register of Toxicologists - the BTS is a sponsoring organisation and work closely with the Chair of the Panel of the UK Register, Mark Hosford, who is also is an ex officio member of the BTS Executive Committee and provides an annual report to the Annual General Meeting of the BTS. The UK Register also provides a bursary to support the cost of attendance at the BTS Annual Congress. My thanks to Colin Davies who stepped down in January of this year as Chair of the UKRT.
- Royal Society of Chemistry (RSC) - The Toxicology Interest Group promote toxicology and support the BTS and awards a poster prize at the BTS Annual Congress. This year the RSC Toxicology Group, along with the Computational and in silico Toxicology Speciality Section, have organised a symposium at this year's Annual Congress on "Building confidence in computational models for decision making in Risk Assessment'"
- The Royal Society of Biology (RSB) - the BTS is a Member Organisation. This facilitates communication and the BTS can contribute to consultation papers and policy documents which are coordinated by the RSB. The RSB also hosts an annual pre-Christmas Parliamentary Reception which was virtual this year, at which the BTS is represented. There have been other Parliamentary events provided by the RSB and the BTS are represented on these.
- EUROTOX - as the UK National Toxicology Society, the BTS participates in the Annual Business meeting of EUROTOX which is held at the annual congress. Despite recent political changes in Europe, links between the BTS and other European Toxicology Societies remain strong and active. The current president of EUROTOX, Professor Heather Wallace is a former president of the BTS.
- International Union of Toxicology (IUTOX) - represents more than 25,000 members and the BTS is one of approximately 60 different member societies. IUTOX organises a scientific congress at 3 yearly intervals. Along with other member societies, the BTS contributes financially to IUTOX via levy, which is based on the number of BTS members. The BTS is represented at meetings of the IUTOX General Assembly, can nominate candidates for appointment to committees and can vote at business meetings. Professor Heather Wallace is an advisor on IUTOX.
- American College of Toxicology (ACT) - The BTS co-sponsors the Practical Application of Toxicology in Drug Development Course (PATDD) at the University of Cambridge. The Programme Committee includes representation from the BTS (Drs Chris Powell and Ernie Harpur), ACT and the University of Cambridge. Together with the ACT the BTS co-sponsors the signature webinars which are available free to our members.
- Royal College of Pathologists (RCPath) - the BTS has a representative (Professor Shirley Price) on the RCPath Specialty Advisory Committee on Toxicology. The RCPath offers professional examinations in Toxicology and BTS Members can participate in the RCPath scheme for recording and accreditation Continuing Professional Development.
- National Centre for 3Rs (NC3Rs) -The BTS continues to work closely with NC3Rs to promote the reduction, refinement, and replacement of experimental animals. In collaboration with the Health and Safety Executive's Chemicals Regulation Division, the NC3Rs hosted a two-day virtual workshop "Increasing confidence in New Approach Methodologies (NAMs) for regulatory decision making".
- In Vitro Toxicology Society (IVTS)- awards a poster prize at the BTS Annual Congress each year and fully supports the BTS. This year the IVTS are supporting the symposium "In Silico Toxicology - Data, Concepts, and Pitfalls" at this year's Congress. Dr Martin Clift is the IVTS representative on the Scientific Subcommittee.
- UK Environmental Mutagen Society (UKEMS) -the BTS works with UKEMS in supporting the scientific training for genetic toxicologists.
- The British Society of Toxicological Pathologists (BSTP) -the BTS works closely with the BSTP and have in the past organised joint meetings. Dr Catherine Ross is the BSTP representative on the Scientific Subcommittee.
- Integrated Toxicology Training Partnership (ITTP)- The ITTP is an initiative launched by the MRC with the aim of improving and boosting capacity in the toxicological sciences by sponsoring PhD studentships. The ITTP is managed through the MRC Toxicology Unit with an expert Steering Committee and seeks to provide to relevant stakeholders in academia, industry and government the expertise in toxicology and related disciplines that is required to ensure the safe and effective development of drugs and exposure to chemicals. The BTS has very close links with the ITTP programme and Professor Marion Macfarlane is the ITTP representative on the Scientific Subcommittee.
The Executive Committee are looking to establish closer links with other Professional Bodies and Learned Societies such as the Society of Environmental Toxicology and Chemistry (SETAC).
Page 7
**The British Toxicology Society**
**President's Report for the Year Ended 31 December 2021**
## **In Memoriam**
As we come to the end of this Society year 2021/22, we should take a moment to think of those members who passed away. The following members and gave so much to the Society, its members, and the science of toxicology namely: - Dr Frank Sullivan
- Dr Malcolm Blackwell
- Professor Kevin Park
## **Gratias Tibi**
Finally, I would like to thank a few people who have worked extremely hard on your behalf, the membership.
Firstly, thanks to our immediate Past President and Chair of NSC, Dr Chris Powell, for his sterling leadership over the two years 2020-20202. Chris has been supporting the Society through several roles and in total has provided 16 years' service.
My thanks to Dr Carol Courage for her sterling work as the General Secretary (2021-2022). A role that is key to the Society and one that requires stamina and diplomacy. Carol has served as the General Secretary keeping the Society and the Executive Committee on track: not an easy task! Carol, you have been a fantastic General Secretary and my thanks for the support you have given me as President and the support given to the Society.
Dr Tina Mehta (2016-2022) leaves the role as Chair of the ETCD Subcommittee and An ordinary member of the Executive Committee. Tina has served in this role and as an ordinary member since 2016. My thanks to you, Tina, for your support of the Society in your various roles.
Dr Jason Gill (2018-2022) leaves the role as Chair of the Scientific Subcommittee of the Executive Committee. Jason has served in this role since 2018. My thanks to you, Jason, for your support to the Society through chairing the Scientific Subcommittee during a difficult time due to the Pandemic.
I would also like to thank Dr Guy Healing who steps down from the NewsFeed Editorial Team after 6 years. Thank you, Guy, for your contribution to the Team and to the Society in the many roles you have held including that of the Treasurer.
Finally, to the Officers and members of the Executive Committee who give their skills and time freely to help run the Society and promote Toxicology my thanks to you all for the support you have given the Society and to me personally as President over the last two years.
Thanks are also due to the Chairs, Co-ordinators, members of the BTS subcommittees and Speciality Sections, the Editorial Team and Ambassadors for your support also.
As ever, I am extremely grateful to our secretariat Executive Business Support Ltd (EBS) for the administrative support provided to the Society and in particular to Gail Ryan, Steve Hewitt, Freya-Louise Andrews and Shona Hunt for their valued assistance in the support given to the BTS and to me personally.
Finally, my thanks to you, the members, for your support and loyalty to the BTS.
Professor Shirley Price, President of the BTS
Page 8
**The British Toxicology Society**
**Operating and Financial Review for the Year Ended 31 December 2021**
## **Overview**
BTS finances remain in an adequate state. The BTS has a policy in alignment with the rules of the Charity Commission to set aside unrestricted financial reserves equivalent to up to 30 months of expenditure to ensure coverage of operating costs during times of financial distress. Expenditure during 2021 averaged £7.7k/month, which equates to £230k over a 30-month period. The total funds carried forward from 2021 were £379k and so the Society is currently meeting this obligation.
## **Changes to Standard Financial Operations**
A minor change was implemented during this reporting period to improve accountability and transparency; a small value purchase order system was implemented to improve control over spending and provide a contractual framework for suppliers.
## **Contribution to Meetings, Events, Awards and Training**
The annual congress was run as a virtual meeting in 2021. Overhead costs associated with virtual meetings are significantly lower than traditional meetings and so this activity generated a modest surplus of £5,482. Normally, the Society would expect to subsidise the annual congress by ~ £5k - 20k.
The Society contributed £993 to support scientific meetings (e.g., webinars) and provided £3,022 in awards (e.g., Early Career Prize, Patton Prize, Studentships). In addition, £1,860 was invested in a package of Equality, Diversity and Inclusion measures (e.g., training and reviews of web content & public documents) to ensure compliance of the Society with legislative obligations.
## **Subscriptions to Other Learned Societies**
Institutional subscriptions to other societies (e.g., Eurotox, IUTOX, Royal Society of Biology, etc.) totalled £6,505. Such memberships provide additional benefits to BTS members and further consolidates the BTS as an internationally recognised professional body.
## **Donations to BTS**
Corporate donations to the Society were very generous under the circumstances and are discussed in more detail in the President's AGM report. For the reporting period January - December 2021, a total of £11,250 was receipted to support the general work of the BTS. A further £4,899 was received towards the cost of the virtual congress. I would like to take this opportunity to personally thank all those institutions and companies who have continue to support the Society during the pandemic.
## **Advertising Income**
Income from advertising on the BTS website marginally increased to £8,150 during this financial year. Advertising costs and associated policy are to be reviewed in 2022 to ensure that the cost of advertising (and policies relating to the placement of notifications) continue to provide membership benefit as well as meeting the financial requirements of the Society.
## **Surplus**
This year was significantly impacted by the COVID pandemic, during which the activities of the Society were significantly curtailed by HM Government restrictions. For example, it was not possible to hold the Annual Congress, which normally runs at a loss of £5 - £20k. In contrast, income generated through membership fees remained relatively static. Consequently, there was a second, consecutive period of unexpected surplus. It should be noted that this surplus is primarily the result of decreased activity associated with the COVID pandemic and so represents an aberration from the normal finances of the Society. A plan to spend this surplus for the benefit of our members has been incorporated into the 2022 budget.
## **Future (2022) Budget**
The temporary reduction in BTS activities due to the on-going pandemic has resulted in a financial surplus for two consecutive years. As the primary aim of the BTS is to provide benefits for its members, it has provisionally been agreed to incorporate the following additional expenditure into the 2022 budget, which is forecast to result in an operational deficit of £31,055 for the period January - December 2022 (excluding any subsidy to the BTS annual congress).
Page 9
**The British Toxicology Society**
## **Operating and Financial Review for the Year Ended 31 December 2021**
## a. Project Co-ordinator position (£25k).
- b. Increased funding of subcommittee activities and speciality groups to enhance current operations (£5k). c. Improvements to BTS website (£6.2k).
The main objective for the project coordinator role will be to develop a training schedule to cover the principles required to develop a risk-based scientist across the discipline of safety sciences. This information will be shared with stakeholders and educational providers to ensure that the UK remains at the forefront of delivering relevant training and education for future generations of toxicologists.
Prof R P Chilcott BTS Treasurer
Page 10
**The British Toxicology Society**
**Report of the Trustees for the Year Ended 31 December 2021**
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2021. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
## **OBJECTIVES AND ACTIVITIES**
## **Objectives and significant activities**
The Society is established for the promotion and advancement, for the public benefit, of education in the science of toxicology. In deciding the aims and activities of the society, the trustees have paid due regard to the guidance issued by the Charity Commission on public benefit. Toxicology is the science of disease induced by chemicals present in the diet, medicines, and in the environment. The British Toxicology Society (BTS) is a leading international toxicology society, based on the highest quality science, and promotes the advancement, communication and understanding of the scientific disciplines necessary to foster public health and environmental safety.
## **STRUCTURE, GOVERNANCE AND MANAGEMENT Governing document**
The Society is a company limited by guarantee and the liability of members is limited to an amount not exceeding £1. It is exempt under Section 60 of the Companies Act 2006 from the requirement to use the word 'Limited' in its title. The Society is governed by the Memorandum and Articles of Association. It is registered with the Charities Commission, number 286197, and no liability to taxation arises.
The Executive Committee are Directors for the purpose of company law and Trustees for the purpose of charity law. Directors/Trustees are appointed by the Society's members at the Annual General Meeting. When a Trustee retires, the Executive Committee nominates new Trustees. Additional nominations may be made by the membership, provided they are signed by six members of the Society.
Informal induction procedures are in place for new Trustees, conducted by an existing member of the Executive Committee and they are also provided with relevant documentation to formally advise and inform them of the Society's constitution and objectives and also their duties and responsibilities as a trustee.
One third of the Executive Committee ordinary members retire each year in rotation but are then eligible for re-election. The society is organised so that the Trustees, in the form of the Executive Committee, meet regularly, usually on a quarterly basis, to manage its affairs. There are also sub-committees which are responsible for advising and researching the various activities and development of the Society, who report to the Executive Committee. Statutes for the workings of the various sub-committees are continually being revised and updated to ensure that the terms of reference are clearly defined and the ways of working are consistent. This also enables transparency of committee elections and duration of membership, while allowing the committees to work to agreed aims, backed up by comprehensive set of Standard Operating Procedures for the Society.
The trustees have assessed the major risks to which the Society is exposed, in particular those related to the operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks. All of the officers and members who serve on the Society's committees are unpaid. They are entitled to be reimbursed for any out of pocket expenses incurred in attending meetings.
No related parties, related party transactions, beneficial relationships or conflicts of interest requiring disclosure by the Charities' or Companies' Acts existed during the year.
Attendance by Executive Committee members has been reasonable throughout the year. The co-opted members continue to provide liaison with the relevant Sub-Committees and Speciality Sections.
The day to day administration of the Society is undertaken by an outside agency on a fee basis.
## **REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number**
01676618 (England and Wales)
## **Registered Charity number**
286197
Page 11
**The British Toxicology Society**
**Report of the Trustees for the Year Ended 31 December 2021**
## **Registered office**
Executive Business Support Limited City Wharf Davidson Road Lichfield Staffordshire WS14 9DZ
## **Trustees**
Dr D J Benford Toxicologist (resigned 12/4/2021) Dr J Gill Reader In Molecular Therapeutics (resigned 4/4/2022) Professor B G Lake Toxicologist Dr E Marczylo Toxicologist Dr E Martin Toxicologist (resigned 12/4/2021) Dr D R Mason Toxicological Safety Dr J Mehta Toxicologist (resigned 4/4/2022) Dr C J Powell Histopathologist (resigned 4/4/2022) Professor S C Price Professor Of Toxicology Dr J Thompson Physician Dr F Sewell Programme Manager Dr P A Botham Toxicologist Dr L M Reeve Toxicologist Dr C Courage (appointed 12/4/2021) (resigned 4/4/2022) Prof. R Chilcott (appointed 12/4/2021) Dr I Copple (appointed 4/4/2022) Dr B Ross (appointed 4/4/2022) Dr H Matar (appointed 4/4/2022)
**Company Secretary** Professor S C Price
## **Independent Examiner**
Jonathon Dickens ACA Sutton McGrath Hartley 5 Westbrook Court Sharrowvale Road Sheffield South Yorkshire S11 8YZ
Approved by order of the board of trustees on 28 September 2022 and signed on its behalf by:
Prof. R Chilcott - Trustee
Page 12
## **Independent Examiner's Report to the Trustees of The British Toxicology Society**
## **Independent examiner's report to the trustees of The British Toxicology Society ('the Company')**
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2021.
## **Responsibilities and basis of report**
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Jonathon Dickens ACA Sutton McGrath Hartley 5 Westbrook Court Sharrowvale Road Sheffield South Yorkshire S11 8YZ
29 September 2022
Page 13
**The British Toxicology Society**
## **Statement of Financial Activities for the Year Ended 31 December 2021**
|Unrestricted
Restricted
fund
funds
Notes
£
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
**65,654**
**-**
**Charitable activities**
Annual Congress
**25,564**
**-**
Annual Congress trade exhibition
**3,375**
**-**
PATDD, ACT joint meetings, webinars and online
events
**20,278**
**-**
Other trading activities
2
**9,890**
**-**
Investment income
3
**1,524**
**21**
**Total**
**126,285**
**21**
**EXPENDITURE ON**
Raising funds
4
**29,290**
**-**
**Charitable activities**
5
Annual Congress
**11,680**
**-**
PATDD, ACT joint meetings, webinars and online
events
**22,286**
**-**
Donations and subscriptions to other societies
**6,607**
**-**
Travel bursaries and early career support
**3,124**
**-**
Other
**18,871**
**-**
**Total**
**91,858**
**-**
**NET INCOME**
**34,427**
**21**
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
**345,064**
**9,962**
**TOTAL FUNDS CARRIED FORWARD**
**379,491**
**9,983**|**2021**
**Total**
**funds**
**£**
**65,654**
**25,564**
**3,375**
**20,278**
**9,890**
**1,545**
**126,306**
**29,290**
**11,680**
**22,286**
**6,607**
**3,124**
**18,871**
**91,858**
**34,448**
**355,026**
**389,474**|2020
Total
funds
£
69,114
-
-
15,786
10,255
2,205
97,360
28,179
23,286
4,257
6,990
1,599
14,451
78,762
18,598
336,428
355,026|
|---|---|---|
The notes form part of these financial statements
Page 14
## **The British Toxicology Society**
## **Balance Sheet**
## **31 December 2021**
|Unrestricted
Restricted
fund
funds
Notes
£
£
**CURRENT ASSETS**
Debtors
9
**28,370**
**-**
Cash at bank
**368,595**
**9,983**
**396,965**
**9,983**
**CREDITORS**
Amounts falling due within one year
10
**(17,474)**
**-**
**NET CURRENT ASSETS**
**379,491**
**9,983**
**TOTAL ASSETS LESS CURRENT LIABILITIES**
**379,491**
**9,983**
**NET ASSETS**
**379,491**
**9,983**
**FUNDS**
11
Unrestricted funds
Restricted funds
**TOTAL FUNDS**|**2021**
**Total**
**funds**
**£**
**28,370**
**378,578**
**406,948**
**(17,474)**
**389,474**
**389,474**
**389,474**
**379,491**
**9,983**
**389,474**|2020
Total
funds
£
41,391
387,799
429,190
(74,164)
355,026
355,026
355,026
345,064
9,962
355,026|
|---|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
continued...
Page 15
**The British Toxicology Society**
## **Balance Sheet - continued**
## **31 December 2021**
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 28 September 2022 and were signed on its behalf by:
R Chilcott - Trustee
S C Price - Trustee
The notes form part of these financial statements
Page 16
**The British Toxicology Society**
**Notes to the Financial Statements for the Year Ended 31 December 2021**
## **1. ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
## **Going concern**
There are no material uncertainties about the charity's ability to continue.
The trustees' assessment of the risks associated with Brexit and the pandemic are detailed in the President's report.
## **Financial reporting standard 102 - reduced disclosure exemptions**
The charitable company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':
- the requirements of Section 7 Statement of Cash Flows;
- the requirement of paragraph 3.17(d);
- the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
- the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
- the requirement of paragraph 33.7.
## **Income**
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
- Income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.
- Legacy income is recognised when receipt is probable and entitlement is established.
- Income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.
- Income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
## **Expenditure**
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
- Expenditure on raising funds includes the costs of all fundraising activities, events, non-charitable trading activities, and the sale of donated goods.
continued...
Page 17
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
## **1. ACCOUNTING POLICIES - continued**
## **Expenditure**
- Expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
- Other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
## **Taxation**
The charity is exempt from corporation tax on its charitable activities.
## **Fund accounting**
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
## **2. OTHER TRADING ACTIVITIES**
|Unrestricted
Restricted
funds
funds
£
£
Website advertising
**8,150**
**-**
OUP / RSC Journal income
**1,740**
**-**
**9,890**
**-**
**INVESTMENT INCOME**
Unrestricted
Restricted
funds
funds
£
£
Deposit account interest
**1,524**
**21**||**2021**
**Total**
**funds**
**£**
**8,150**
**1,740**
**9,890**
**2021**
**Total**
**funds**
**£**
**1,545**|2020
Total
funds
£
7,875
2,380
10,255
2020
Total
funds
£
2,205|
|---|---|---|---|
## **3. INVESTMENT INCOME**
continued...
Page 18
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
## **4. RAISING FUNDS**
## **Raising donations and legacies**
|Unrestricted
Restricted
funds
funds
£
£
Bank charges
**852**
**-**
EBS - membership processing
**10,512**
**-**
Membership discount
**-**
**-**
Support costs
**3,516**
**-**
**14,880**
**-**
**Other trading activities**
Unrestricted
Restricted
funds
funds
£
£
EBS- website management
**9,426**
**-**
ACT webinars
**805**
**-**
Bank charges
**61**
**-**
Publicity materials
**600**
**-**
Support costs
**3,518**
**-**
**14,410**
**-**
Aggregate amounts
**29,290**
**-**|**2021**
**Total**
**funds**
**£**
**852**
**10,512**
**-**
**3,516**
**14,880**
**2021**
**Total**
**funds**
**£**
**9,426**
**805**
**61**
**600**
**3,518**
**14,410**
**29,290**|2020
Total
funds
£
1,003
8,121
61
8,782
17,967
2020
Total
funds
£
5,894
-
35
600
3,683
10,212
28,179|
|---|---|---|
## **5. CHARITABLE ACTIVITIES COSTS**
|Annual Congress
PATDD, ACT joint meetings, webinars
and online events
Donations and subscriptions to other
societies
Travel bursaries and early career
support|Support
Direct
costs (see
Costs
note 6)
£
£
**11,680**
**-**
**17,594**
**4,692**
**5,435**
**1,172**
**1,952**
**1,172**
**36,661**
**7,036**|Totals
£
**11,680**
**22,286**
**6,607**
**3,124**
**43,697**|
|---|---|---|
continued...
Page 19
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
## **6. SUPPORT COSTS**
|Management
£
Raising donations and
legacies
**-**
Other trading activities
**-**
Other resources expended
**7,823**
PATDD, ACT joint meetings,
webinars and online events
**-**
Donations and
subscriptions to other
societies
**-**
Travel bursaries and early
career support
**-**
**7,823**|Information
Governance
Finance
technology
costs
£
£
£
**3,516**
**-**
**-**
**3,518**
**-**
**-**
**-**
**3,491**
**7,557**
**4,692**
**-**
**-**
**1,172**
**-**
**-**
**1,172**
**-**
**-**
**14,070**
**3,491**
**7,557**|Totals
£
**3,516**
**3,518**
**18,871**
**4,692**
**1,172**
**1,172**
**32,941**|
|---|---|---|
## **7. TRUSTEES' REMUNERATION AND BENEFITS**
There were no trustees' remuneration or other benefits for the year ended 31 December 2021 nor for the year ended 31 December 2020.
## **Trustees' expenses**
|**2021**
**£**
Trustees' expenses
**426**
**8.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**
Unrestricted
Restricted
fund
funds
£
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
69,114
-
**Charitable activities**
PATDD, ACT joint meetings, webinars and
online events
15,786
-
Other trading activities
10,255
-
Investment income
2,151
54
**Total**
97,306
54
**EXPENDITURE ON**
Raising funds
28,179
-
**Charitable activities**
Annual Congress
23,286
-
PATDD, ACT joint meetings, webinars and
online events
4,257
-
Donations and subscriptions to other
societies
6,990
-||2020
£
341
Total
funds
£
69,114
15,786
10,255
2,205
97,360
28,179
23,286
4,257
6,990|
|---|---|---|
continued...
Page 20
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
|**8.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
Restricted
fund
funds
£
£
Travel bursaries and early career support
1,599
-
Other
14,451
-
**Total**
78,762
-
**NET INCOME**
18,544
54
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
326,520
9,908
**TOTAL FUNDS CARRIED FORWARD**
345,064
9,962
**9.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
**2021**
**£**
Debtors
**5,540**
Prepayments &
accrued income
**22,830**
**28,370**
**10.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
**2021**
**£**
Trade creditors
**4,365**
Accruals & prepaid income
**13,109**
**17,474**|Total
funds
£
1,599
14,451
78,762
18,598
336,428
355,026
2020
£
114
41,277
41,391
2020
£
7,647
66,517
74,164|
|---|---|
continued...
Page 21
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
## **11. MOVEMENT IN FUNDS**
|**MOVEMENT IN FUNDS**||||||
|---|---|---|---|---|---|
||||Net|||
||||movement||At|
||At 1/1/21||in funds|31/12/21||
|||£|£||£|
|**Unrestricted funds**||||||
|General fund||**345,064**|**34,427**||**379,491**|
|**Restricted funds**||||||
|Barnes fund||**811**|**1**||**812**|
|Paton fund||**3,768**|**2**||**3,770**|
|Norman Aldridge fund||**5,383**|**18**||**5,401**|
|||**9,962**|**21**||**9,983**|
|**TOTAL FUNDS**||**355,026**|**34,448**||**389,474**|
|Net movement in funds, included in the above are as follows:||||||
|**Unrestricted funds**|Incoming
resources
£||Resources
expended
£|Movement
in funds
£||
|General fund||**126,285**|**(91,858)**||**34,427**|
|**Restricted funds**||||||
|Barnes fund||**1**|**-**||**1**|
|Paton fund||**2**|**-**||**2**|
|Norman Aldridge fund||**18**|**-**||**18**|
|||**21**|**-**||**21**|
|**TOTAL FUNDS**||**126,306**|**(91,858)**||**34,448**|
|**Comparatives for movement in funds**||||||
|**Unrestricted funds**|At 1/1/20
£||Net
movement
in funds
£|At
31/12/20
£||
|General fund||326,520|18,544||345,064|
|**Restricted funds**||||||
|Barnes fund||808|3||811|
|Paton fund||3,759|9||3,768|
|Norman Aldridge fund||5,341|42||5,383|
|||9,908|54||9,962|
|**TOTAL FUNDS**||336,428|18,598||355,026|
|||||||
continued...
Page 22
**The British Toxicology Society**
## **Notes to the Financial Statements - continued for the Year Ended 31 December 2021**
## **11. MOVEMENT IN FUNDS - continued**
Comparative net movement in funds, included in the above are as follows:
||Incoming|Resources|Movement|Movement|
|---|---|---|---|---|
||resources|expended||in funds|
||£|£||£|
|**Unrestricted funds**|||||
|General fund|97,306|(78,762)||18,544|
|**Restricted funds**|||||
|Barnes fund|3|-||3|
|Paton fund|9|-||9|
|Norman Aldridge fund|42|-||42|
||54|-||54|
|**TOTAL FUNDS**|97,360|(78,762)||18,598|
||||||
Restricted funds comprise donations given to provide lecture awards, travel grants and support to early career toxicologists. Awards are made by the trustees on an alternate year basis.
## **12. RELATED PARTY DISCLOSURES**
There were no related party transactions.
Page 23
**The British Toxicology Society**
## **Detailed Statement of Financial Activities for the Year Ended 31 December 2021**
|Unrestricted
Restricted
funds
funds
£
£
**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
**11,250**
**-**
Subscriptions
**54,404**
**-**
**65,654**
**-**
**Other trading activities**
Website advertising
**8,150**
**-**
OUP / RSC Journal income
**1,740**
**-**
**9,890**
**-**
**Investment income**
Deposit account interest
**1,524**
**21**
**Charitable activities**
Annual Congress delegates
**20,665**
**-**
Annual Congress donations
**4,899**
**-**
Annual Congress exhibitors and trade stands
**3,375**
**-**
PATDD & ACT joint meetings & webinars
**20,278**
**-**
**49,217**
**-**
**Total incoming resources**
**126,285**
**21**
**EXPENDITURE**
**Raising donations and legacies**
Bank charges
**852**
**-**
EBS - membership processing
**10,512**
**-**
Membership discount
**-**
**-**
**11,364**
**-**
**Other trading activities**
EBS- website management
**9,426**
**-**
ACT webinars
**805**
**-**
Bank charges
**61**
**-**
Publicity materials
**600**
**-**
**10,892**
**-**
**Charitable activities**
Publicity
**19**
**-**
Carried forward
**19**
**-**|2021
Total
funds
£
**11,250**
**54,404**
**65,654**
**8,150**
**1,740**
**9,890**
**1,545**
**20,665**
**4,899**
**3,375**
**20,278**
**49,217**
**126,306**
**852**
**10,512**
**-**
**11,364**
**9,426**
**805**
**61**
**600**
**10,892**
**19**
**19**|2020
Total
funds
£
14,000
55,114
69,114
7,875
2,380
10,255
2,205
-
-
-
15,786
15,786
97,360
1,003
8,121
61
9,185
5,894
-
35
600
6,529
-
-|
|---|---|---|
This page does not form part of the statutory financial statements
Page 24
**The British Toxicology Society**
## **Detailed Statement of Financial Activities for the Year Ended 31 December 2021**
|Unrestricted
Restricted
funds
funds
£
£
**Charitable activities**
Brought forward
**19**
**-**
Insurance
**-**
**-**
Entertainment
**30**
**-**
Speakers' expenses
**2,068**
**-**
Joint meeting costs
**-**
**-**
Bank charges
**37**
**-**
EBS management fee
**25,034**
**-**
EBS travel expenses
**-**
**-**
EBS processing fees
**1,516**
**-**
Eurotox subscription
**1,690**
**-**
Understanding Animal Research
**266**
**-**
Society of Biology
**690**
**-**
Iutox International
**2,759**
**-**
Science workshops
**600**
**-**
Early career prizes
**420**
**-**
Travel bursary
**-**
**-**
Studentship
**1,208**
**-**
Oral presentation prize
**100**
**-**
Recognition awards
**224**
**-**
**36,661**
**-**
**Support costs**
**Management**
Postage and stationery
**269**
**-**
EBS- trustee support
**7,554**
**-**
**7,823**
**-**
**Finance**
EBS- bookkeeping & finance
**14,070**
**-**
**Information technology**
EBS- licences & IT support
**3,491**
**-**
Members survey
**-**
**-**
**3,491**
**-**
**Governance costs**
Meeting expenses - trustees
**426**
**-**
Accountancy fees
**7,026**
**-**
Company secretarial and AGM
**13**
**-**
Meeting expenses- non trustees
**92**
**-**
Meeting expenses- room hire
**-**
**-**
**7,557**
**-**|2021
Total
funds
£
**19**
**-**
**30**
**2,068**
**-**
**37**
**25,034**
**-**
**1,516**
**1,690**
**266**
**690**
**2,759**
**600**
**420**
**-**
**1,208**
**100**
**224**
**36,661**
**269**
**7,554**
**7,823**
**14,070**
**3,491**
**-**
**3,491**
**426**
**7,026**
**13**
**92**
**-**
**7,557**|2020
Total
funds
£
-
787
150
-
586
123
19,032
119
1,864
1,731
264
690
3,048
-
-
372
-
-
-
28,766
534
6,317
6,851
11,731
3,000
5,100
8,100
341
6,601
34
606
18
7,600|
|---|---|---|
This page does not form part of the statutory financial statements
Page 25
**The British Toxicology Society**
## **Detailed Statement of Financial Activities for the Year Ended 31 December 2021**
|Unrestricted
Restricted
funds
funds
£
£
Total resources expended
**91,858**
**-**
**Net income**
**34,427**
**21**|2021
Total
funds
£
**91,858**
**34,448**|2020
Total
funds
£
78,762
18,598|
|---|---|---|
This page does not form part of the statutory financial statements
Page 26